Hematopoietic Stem Cell-derived Adipocytes Promote Tumor Growth and Cancer Cell Migration

Area of Science:

• Oncology
• Cell Biology
• Immunology

Background:

• Adipocytes are key components of the tumor microenvironment.
• Previous studies identified hematopoietic stem cells (HSCs) as a source of adipocytes via monocyte/macrophage progenitors.

Purpose of the Study:

• To investigate the role of HSC-derived adipocytes (HSC-Ad) in tumor progression.
• To elucidate the mechanisms by which HSC-Ad influence tumor growth, vascularization, proliferation, and migration.

Main Methods:

• Differentiation of bone marrow-derived monocytic progenitors into adipocytes in vitro.
• Co-injection of HSC-Ad with melanoma (B16F1) and breast cancer (E0771) cells in C57Bl/6 mice.
• Analysis of adipokine secretion by HSC-Ad using adipokine arrays and ELISAs.
• Assessment of tumor growth, vascularization, cell proliferation, and migration in vivo and in vitro.

Main Results:

• HSC-Ad accelerated melanoma and breast tumor growth and enhanced tumor vascularization.
• Conditioned media from HSC-Ad promoted cancer cell proliferation and migration in vitro.
• Secreted adipokines, including IGF-1, HGF, and PDGF-BB, differentially regulated cancer cell behavior.
• Expression of receptors for these adipokines correlated with their functional roles.

Conclusions:

• HSC-Ad represent a novel cellular component that actively promotes tumor progression.
• HSC-Ad exert their pro-tumorigenic effects through the secretion of specific adipokines that influence cancer cell proliferation and migration.
• These findings highlight a complex interplay between HSC-derived adipocytes and the tumor microenvironment, suggesting potential therapeutic targets.